MPG.eBooks - Search Results

Cover Image

1

Somatropin (Genotropin) for subcutaneous injection : the treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed

Published 2014

CADTH

Cover Image

2

Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

3

Human growth hormone treatment for Prader-Willi syndrome in adolescent and adult patients: clinical evidence, safety, and guidelines

Published 2015

CADTH Rapid Response Service

Cover Image

4

Human growth hormone treatment for adult growth hormone deficiency : a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines

Published 2015

CADTH Rapid Response Service

Cover Image

5

Storage, handling, and administration of expressed human breast milk : a review of guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

Masks for prevention of influenza transmission in acute and long-term care settings : a review of clinical effectiveness, cost-effectiveness and guidelines

by Marchand, Dave K., Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

8

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

9

Clinical review report: Burosumab (Crysvita) (Kyowa Kirin limited) : indication: for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of age and...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

10

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris -- Alexion Pharma Canada Corp.) : indication : adult patients with refractory generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

11

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada Corp.) : indication : the treatment of neuromyelitis optica spectrum disorder (NMOS...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

12

Clinical review report: Eculizumab (Soliris) : Alexion Pharma Canada corporation : indication : adult patients with generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

13

Pharmacoeconomic report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

14

Clinical review report: Ofatumumab (Kesimpta) (Novartis Pharmaceuticals Canada Inc.) : indication: multiple sclerosis, relapsing-remitting

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

15

Clinical and economic review report: Vedolizumab (ENTYVIO SC) Takeda Canada Inc. : indication: Crohn disease

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

16

Masks for prevention of influenza transmission in acute and long-term care settings : a review of clinical effectiveness, cost-effectiveness and guidelines

by Marchand, Dave K., Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

17

Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : for the treatment of adult patients with active ankylosing spondylitis who have responded inadequa...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

18

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

19

Clinical review report: Burosumab (Crysvita) (Kyowa Kirin limited) : indication: for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of age and...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

20

Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...

Published 2020

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6